Global Biological Sample Handling Market

Biological Sample Handling Comprehensive Study by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies, Others), Sample Type (Blood and Blood Fractions, Tissue, Urine, Saliva, Bone Marrow, Semen, Others), Risk Group Pathogens (Risk Group 1, Risk Group 2, Risk Group 3, Risk Group 4), Extraction Technique (Buccal Swab, Venipuncture, Fingerstick, Biopsy, Hair Analysis, Others), Preservation Method (Room Temperature, Refrigerator, Freezer, Liquid Nitrogen Vapour, Liquid Nitrogen Liquid Phase) Players and Region - Global Market Outlook to 2026

Biological Sample Handling Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biological Sample Handling Market Scope?
Biological sample handling is a process of collecting, storing, and processing biological samples for further study or use. Compound management and biological sample management play an important role in drug discovery and DNA extraction. In addition, the collection and storage of human biological samples support the research and development industry in the identification of diseases and promote the trend towards the provision of personalized medicines. Biological sample handling deals with various applications such as forensic investigation, the study of proteomics and genomics, and so on. The sample is stored either in cold storage or at room temperature. Growing concern for the integrity and safety of samples is the main driver for this market. The IT implementation in healthcare will support and simplify the handling of samples. There are various organizations such as the Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI), the International Agency for Research on Cancer (IARC), the International Society for Biological and Ecological Repositories (ISBER), the National Cancer Institute (NCI), and the Public Population Project in Genomics (p3G), which help provide funding and alert people to regulations and guidelines for handling biological samples.

The Biological Sample Handling market study is being classified, by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics and Genomics Studies and Others) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Biological Sample Handling market throughout the predicted period.

Alliance Pharma (United Kingdom), Abbott Laboratories (United States), Becton Dickinson (United States), Sigma-Aldrich (United States), BioRepository Resources, LLC (United States), Brooks Automation, Inc. (United States), Conversant Bio. (United States), Cryopoint (United States), Fisher BioServices (United States), Indivumed GmbH (Germany), Masy BioServices (United States), Sentry BioPharma Services (United States), ProteoGenex (United States), ReproCELL Europe Ltd. (United Kingdom), Tescor Inc. (United States) and Technidata (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are PrecisionMed (United States), ProMedDx (United States) and SciSafe (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biological Sample Handling market by Type, Application and Region.

On the basis of geography, the market of Biological Sample Handling has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).


All Institutional Biosafety Committees (IBSCs) must assess the facilities available, workers, trained in handling hazardous high-risk microorganisms (RG3 and above), personal protective equipment (PPE), and waste disposal mechanisms to meet all requirements prior to commencing work. All applications for the development of vaccines, diagnostics, prophylactic and therapeutic agents are checked by RCGM and CDSCO in accordance with DBT OM No. BT / 03/27/2020-PID dated March 20, 2020, as part of the Rapid Response Regulatory Framework for COVID-19. Patient samples from suspected or confirmed cases should be shipped as UN3373, "Biological Substance Category B". Virus cultures of isolates should be transported as Category A, UN2814, “Infectious Substance Affecting Humans” and transported according to WHO Guidelines on Regulations for the Transport of Infectious Substances 2017-2018.

Influencing Market Trend
  • Adoption of IT in Healthcare
  • The Growing Need for Quality Sample and the Need for Personalized Treatment
  • Increasing FDA Approval for Drug Discovery

Market Drivers
  • The Increasing Demand for Quality Sample
  • The Growing Need for Personalized, Precision and Genomic Medicine
  • The Increasing Popularity of Precision/Personalized Medicine and Genetic Testing

Opportunities
  • An Increase in Demand for Biospecimens from Clinical Labs to Develop Assays for Genetic Testing
  • The Increasing Healthcare Expenditure
  • The Increased Spending For R&D in Personalized Treatment

Restraints
  • High Capital Investment for the Collection of Samples and the Storage

Challenges
  • The Lack of Infrastructure for Storing and Maintaining Samples


Key Target Audience
Providers of Veterinary Care, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Drug Discovery
  • Forensic Investigation
  • DNA Extraction
  • Proteomics and Genomics Studies
  • Others
By Sample Type
  • Blood and Blood Fractions
  • Tissue
  • Urine
  • Saliva
  • Bone Marrow
  • Semen
  • Others

By Risk Group Pathogens
  • Risk Group 1
  • Risk Group 2
  • Risk Group 3
  • Risk Group 4

By Extraction Technique
  • Buccal Swab
  • Venipuncture
  • Fingerstick
  • Biopsy
  • Hair Analysis
  • Others

By Preservation Method
  • Room Temperature
  • Refrigerator
  • Freezer
  • Liquid Nitrogen Vapour
  • Liquid Nitrogen Liquid Phase

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Demand for Quality Sample
      • 3.2.2. The Growing Need for Personalized, Precision and Genomic Medicine
      • 3.2.3. The Increasing Popularity of Precision/Personalized Medicine and Genetic Testing
    • 3.3. Market Challenges
      • 3.3.1. The Lack of Infrastructure for Storing and Maintaining Samples
    • 3.4. Market Trends
      • 3.4.1. Adoption of IT in Healthcare
      • 3.4.2. The Growing Need for Quality Sample and the Need for Personalized Treatment
      • 3.4.3. Increasing FDA Approval for Drug Discovery
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biological Sample Handling, by Application, Sample Type, Risk Group Pathogens, Extraction Technique, Preservation Method and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biological Sample Handling (Value)
      • 5.2.1. Global Biological Sample Handling by: Application (Value)
        • 5.2.1.1. Drug Discovery
        • 5.2.1.2. Forensic Investigation
        • 5.2.1.3. DNA Extraction
        • 5.2.1.4. Proteomics and Genomics Studies
        • 5.2.1.5. Others
      • 5.2.2. Global Biological Sample Handling by: Sample Type (Value)
        • 5.2.2.1. Blood and Blood Fractions
        • 5.2.2.2. Tissue
        • 5.2.2.3. Urine
        • 5.2.2.4. Saliva
        • 5.2.2.5. Bone Marrow
        • 5.2.2.6. Semen
        • 5.2.2.7. Others
      • 5.2.3. Global Biological Sample Handling by: Risk Group Pathogens (Value)
        • 5.2.3.1. Risk Group 1
        • 5.2.3.2. Risk Group 2
        • 5.2.3.3. Risk Group 3
        • 5.2.3.4. Risk Group 4
      • 5.2.4. Global Biological Sample Handling by: Extraction Technique (Value)
        • 5.2.4.1. Buccal Swab
        • 5.2.4.2. Venipuncture
        • 5.2.4.3. Fingerstick
        • 5.2.4.4. Biopsy
        • 5.2.4.5. Hair Analysis
        • 5.2.4.6. Others
      • 5.2.5. Global Biological Sample Handling by: Preservation Method (Value)
        • 5.2.5.1. Room Temperature
        • 5.2.5.2. Refrigerator
        • 5.2.5.3. Freezer
        • 5.2.5.4. Liquid Nitrogen Vapour
        • 5.2.5.5. Liquid Nitrogen Liquid Phase
      • 5.2.6. Global Biological Sample Handling Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Biological Sample Handling (Price)
  • 6. Biological Sample Handling: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alliance Pharma (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton Dickinson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sigma-Aldrich (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioRepository Resources, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Brooks Automation, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Conversant Bio. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cryopoint (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fisher BioServices (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Indivumed GmbH (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Masy BioServices (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Sentry BioPharma Services (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. ProteoGenex (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. ReproCELL Europe Ltd. (United Kingdom)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Tescor Inc. (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Technidata (France)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Biological Sample Handling Sale, by Application, Sample Type, Risk Group Pathogens, Extraction Technique, Preservation Method and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biological Sample Handling (Value)
      • 7.2.1. Global Biological Sample Handling by: Application (Value)
        • 7.2.1.1. Drug Discovery
        • 7.2.1.2. Forensic Investigation
        • 7.2.1.3. DNA Extraction
        • 7.2.1.4. Proteomics and Genomics Studies
        • 7.2.1.5. Others
      • 7.2.2. Global Biological Sample Handling by: Sample Type (Value)
        • 7.2.2.1. Blood and Blood Fractions
        • 7.2.2.2. Tissue
        • 7.2.2.3. Urine
        • 7.2.2.4. Saliva
        • 7.2.2.5. Bone Marrow
        • 7.2.2.6. Semen
        • 7.2.2.7. Others
      • 7.2.3. Global Biological Sample Handling by: Risk Group Pathogens (Value)
        • 7.2.3.1. Risk Group 1
        • 7.2.3.2. Risk Group 2
        • 7.2.3.3. Risk Group 3
        • 7.2.3.4. Risk Group 4
      • 7.2.4. Global Biological Sample Handling by: Extraction Technique (Value)
        • 7.2.4.1. Buccal Swab
        • 7.2.4.2. Venipuncture
        • 7.2.4.3. Fingerstick
        • 7.2.4.4. Biopsy
        • 7.2.4.5. Hair Analysis
        • 7.2.4.6. Others
      • 7.2.5. Global Biological Sample Handling by: Preservation Method (Value)
        • 7.2.5.1. Room Temperature
        • 7.2.5.2. Refrigerator
        • 7.2.5.3. Freezer
        • 7.2.5.4. Liquid Nitrogen Vapour
        • 7.2.5.5. Liquid Nitrogen Liquid Phase
      • 7.2.6. Global Biological Sample Handling Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Biological Sample Handling (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biological Sample Handling: by Application(USD Million)
  • Table 2. Biological Sample Handling Drug Discovery , by Region USD Million (2015-2020)
  • Table 3. Biological Sample Handling Forensic Investigation , by Region USD Million (2015-2020)
  • Table 4. Biological Sample Handling DNA Extraction , by Region USD Million (2015-2020)
  • Table 5. Biological Sample Handling Proteomics and Genomics Studies , by Region USD Million (2015-2020)
  • Table 6. Biological Sample Handling Others , by Region USD Million (2015-2020)
  • Table 7. Biological Sample Handling: by Sample Type(USD Million)
  • Table 8. Biological Sample Handling Blood and Blood Fractions , by Region USD Million (2015-2020)
  • Table 9. Biological Sample Handling Tissue , by Region USD Million (2015-2020)
  • Table 10. Biological Sample Handling Urine , by Region USD Million (2015-2020)
  • Table 11. Biological Sample Handling Saliva , by Region USD Million (2015-2020)
  • Table 12. Biological Sample Handling Bone Marrow , by Region USD Million (2015-2020)
  • Table 13. Biological Sample Handling Semen , by Region USD Million (2015-2020)
  • Table 14. Biological Sample Handling Others , by Region USD Million (2015-2020)
  • Table 15. Biological Sample Handling: by Risk Group Pathogens(USD Million)
  • Table 16. Biological Sample Handling Risk Group 1 , by Region USD Million (2015-2020)
  • Table 17. Biological Sample Handling Risk Group 2 , by Region USD Million (2015-2020)
  • Table 18. Biological Sample Handling Risk Group 3 , by Region USD Million (2015-2020)
  • Table 19. Biological Sample Handling Risk Group 4 , by Region USD Million (2015-2020)
  • Table 20. Biological Sample Handling: by Extraction Technique(USD Million)
  • Table 21. Biological Sample Handling Buccal Swab , by Region USD Million (2015-2020)
  • Table 22. Biological Sample Handling Venipuncture , by Region USD Million (2015-2020)
  • Table 23. Biological Sample Handling Fingerstick , by Region USD Million (2015-2020)
  • Table 24. Biological Sample Handling Biopsy , by Region USD Million (2015-2020)
  • Table 25. Biological Sample Handling Hair Analysis , by Region USD Million (2015-2020)
  • Table 26. Biological Sample Handling Others , by Region USD Million (2015-2020)
  • Table 27. Biological Sample Handling: by Preservation Method(USD Million)
  • Table 28. Biological Sample Handling Room Temperature , by Region USD Million (2015-2020)
  • Table 29. Biological Sample Handling Refrigerator , by Region USD Million (2015-2020)
  • Table 30. Biological Sample Handling Freezer , by Region USD Million (2015-2020)
  • Table 31. Biological Sample Handling Liquid Nitrogen Vapour , by Region USD Million (2015-2020)
  • Table 32. Biological Sample Handling Liquid Nitrogen Liquid Phase , by Region USD Million (2015-2020)
  • Table 33. South America Biological Sample Handling, by Country USD Million (2015-2020)
  • Table 34. South America Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 35. South America Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 36. South America Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 37. South America Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 38. South America Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 39. Brazil Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 40. Brazil Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 41. Brazil Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 42. Brazil Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 43. Brazil Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 44. Argentina Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 45. Argentina Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 46. Argentina Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 47. Argentina Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 48. Argentina Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 49. Rest of South America Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 50. Rest of South America Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 51. Rest of South America Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 52. Rest of South America Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 53. Rest of South America Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 54. Asia Pacific Biological Sample Handling, by Country USD Million (2015-2020)
  • Table 55. Asia Pacific Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 56. Asia Pacific Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 57. Asia Pacific Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 58. Asia Pacific Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 59. Asia Pacific Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 60. China Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 61. China Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 62. China Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 63. China Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 64. China Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 65. Japan Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 66. Japan Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 67. Japan Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 68. Japan Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 69. Japan Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 70. India Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 71. India Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 72. India Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 73. India Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 74. India Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 75. South Korea Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 76. South Korea Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 77. South Korea Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 78. South Korea Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 79. South Korea Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 80. Taiwan Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 81. Taiwan Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 82. Taiwan Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 83. Taiwan Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 84. Taiwan Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 85. Australia Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 86. Australia Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 87. Australia Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 88. Australia Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 89. Australia Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 90. Rest of Asia-Pacific Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 91. Rest of Asia-Pacific Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 92. Rest of Asia-Pacific Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 93. Rest of Asia-Pacific Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 94. Rest of Asia-Pacific Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 95. Europe Biological Sample Handling, by Country USD Million (2015-2020)
  • Table 96. Europe Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 97. Europe Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 98. Europe Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 99. Europe Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 100. Europe Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 101. Germany Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 102. Germany Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 103. Germany Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 104. Germany Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 105. Germany Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 106. France Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 107. France Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 108. France Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 109. France Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 110. France Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 111. Italy Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 112. Italy Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 113. Italy Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 114. Italy Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 115. Italy Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 116. United Kingdom Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 117. United Kingdom Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 118. United Kingdom Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 119. United Kingdom Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 120. United Kingdom Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 121. Netherlands Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 122. Netherlands Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 123. Netherlands Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 124. Netherlands Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 125. Netherlands Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 126. Rest of Europe Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 127. Rest of Europe Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 128. Rest of Europe Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 129. Rest of Europe Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 130. Rest of Europe Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 131. MEA Biological Sample Handling, by Country USD Million (2015-2020)
  • Table 132. MEA Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 133. MEA Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 134. MEA Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 135. MEA Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 136. MEA Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 137. Middle East Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 138. Middle East Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 139. Middle East Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 140. Middle East Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 141. Middle East Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 142. Africa Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 143. Africa Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 144. Africa Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 145. Africa Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 146. Africa Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 147. North America Biological Sample Handling, by Country USD Million (2015-2020)
  • Table 148. North America Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 149. North America Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 150. North America Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 151. North America Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 152. North America Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 153. United States Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 154. United States Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 155. United States Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 156. United States Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 157. United States Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 158. Canada Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 159. Canada Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 160. Canada Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 161. Canada Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 162. Canada Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 163. Mexico Biological Sample Handling, by Application USD Million (2015-2020)
  • Table 164. Mexico Biological Sample Handling, by Sample Type USD Million (2015-2020)
  • Table 165. Mexico Biological Sample Handling, by Risk Group Pathogens USD Million (2015-2020)
  • Table 166. Mexico Biological Sample Handling, by Extraction Technique USD Million (2015-2020)
  • Table 167. Mexico Biological Sample Handling, by Preservation Method USD Million (2015-2020)
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Company Basic Information, Sales Area and Its Competitors
  • Table 177. Company Basic Information, Sales Area and Its Competitors
  • Table 178. Company Basic Information, Sales Area and Its Competitors
  • Table 179. Company Basic Information, Sales Area and Its Competitors
  • Table 180. Company Basic Information, Sales Area and Its Competitors
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Biological Sample Handling: by Application(USD Million)
  • Table 185. Biological Sample Handling Drug Discovery , by Region USD Million (2021-2026)
  • Table 186. Biological Sample Handling Forensic Investigation , by Region USD Million (2021-2026)
  • Table 187. Biological Sample Handling DNA Extraction , by Region USD Million (2021-2026)
  • Table 188. Biological Sample Handling Proteomics and Genomics Studies , by Region USD Million (2021-2026)
  • Table 189. Biological Sample Handling Others , by Region USD Million (2021-2026)
  • Table 190. Biological Sample Handling: by Sample Type(USD Million)
  • Table 191. Biological Sample Handling Blood and Blood Fractions , by Region USD Million (2021-2026)
  • Table 192. Biological Sample Handling Tissue , by Region USD Million (2021-2026)
  • Table 193. Biological Sample Handling Urine , by Region USD Million (2021-2026)
  • Table 194. Biological Sample Handling Saliva , by Region USD Million (2021-2026)
  • Table 195. Biological Sample Handling Bone Marrow , by Region USD Million (2021-2026)
  • Table 196. Biological Sample Handling Semen , by Region USD Million (2021-2026)
  • Table 197. Biological Sample Handling Others , by Region USD Million (2021-2026)
  • Table 198. Biological Sample Handling: by Risk Group Pathogens(USD Million)
  • Table 199. Biological Sample Handling Risk Group 1 , by Region USD Million (2021-2026)
  • Table 200. Biological Sample Handling Risk Group 2 , by Region USD Million (2021-2026)
  • Table 201. Biological Sample Handling Risk Group 3 , by Region USD Million (2021-2026)
  • Table 202. Biological Sample Handling Risk Group 4 , by Region USD Million (2021-2026)
  • Table 203. Biological Sample Handling: by Extraction Technique(USD Million)
  • Table 204. Biological Sample Handling Buccal Swab , by Region USD Million (2021-2026)
  • Table 205. Biological Sample Handling Venipuncture , by Region USD Million (2021-2026)
  • Table 206. Biological Sample Handling Fingerstick , by Region USD Million (2021-2026)
  • Table 207. Biological Sample Handling Biopsy , by Region USD Million (2021-2026)
  • Table 208. Biological Sample Handling Hair Analysis , by Region USD Million (2021-2026)
  • Table 209. Biological Sample Handling Others , by Region USD Million (2021-2026)
  • Table 210. Biological Sample Handling: by Preservation Method(USD Million)
  • Table 211. Biological Sample Handling Room Temperature , by Region USD Million (2021-2026)
  • Table 212. Biological Sample Handling Refrigerator , by Region USD Million (2021-2026)
  • Table 213. Biological Sample Handling Freezer , by Region USD Million (2021-2026)
  • Table 214. Biological Sample Handling Liquid Nitrogen Vapour , by Region USD Million (2021-2026)
  • Table 215. Biological Sample Handling Liquid Nitrogen Liquid Phase , by Region USD Million (2021-2026)
  • Table 216. South America Biological Sample Handling, by Country USD Million (2021-2026)
  • Table 217. South America Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 218. South America Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 219. South America Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 220. South America Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 221. South America Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 222. Brazil Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 223. Brazil Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 224. Brazil Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 225. Brazil Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 226. Brazil Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 227. Argentina Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 228. Argentina Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 229. Argentina Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 230. Argentina Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 231. Argentina Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 232. Rest of South America Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 233. Rest of South America Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 234. Rest of South America Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 235. Rest of South America Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 236. Rest of South America Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 237. Asia Pacific Biological Sample Handling, by Country USD Million (2021-2026)
  • Table 238. Asia Pacific Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 239. Asia Pacific Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 240. Asia Pacific Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 241. Asia Pacific Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 242. Asia Pacific Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 243. China Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 244. China Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 245. China Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 246. China Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 247. China Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 248. Japan Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 249. Japan Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 250. Japan Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 251. Japan Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 252. Japan Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 253. India Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 254. India Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 255. India Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 256. India Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 257. India Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 258. South Korea Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 259. South Korea Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 260. South Korea Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 261. South Korea Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 262. South Korea Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 263. Taiwan Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 264. Taiwan Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 265. Taiwan Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 266. Taiwan Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 267. Taiwan Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 268. Australia Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 269. Australia Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 270. Australia Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 271. Australia Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 272. Australia Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 273. Rest of Asia-Pacific Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 274. Rest of Asia-Pacific Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 275. Rest of Asia-Pacific Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 276. Rest of Asia-Pacific Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 277. Rest of Asia-Pacific Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 278. Europe Biological Sample Handling, by Country USD Million (2021-2026)
  • Table 279. Europe Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 280. Europe Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 281. Europe Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 282. Europe Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 283. Europe Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 284. Germany Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 285. Germany Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 286. Germany Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 287. Germany Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 288. Germany Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 289. France Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 290. France Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 291. France Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 292. France Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 293. France Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 294. Italy Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 295. Italy Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 296. Italy Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 297. Italy Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 298. Italy Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 299. United Kingdom Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 300. United Kingdom Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 301. United Kingdom Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 302. United Kingdom Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 303. United Kingdom Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 304. Netherlands Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 305. Netherlands Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 306. Netherlands Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 307. Netherlands Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 308. Netherlands Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 309. Rest of Europe Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 310. Rest of Europe Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 311. Rest of Europe Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 312. Rest of Europe Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 313. Rest of Europe Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 314. MEA Biological Sample Handling, by Country USD Million (2021-2026)
  • Table 315. MEA Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 316. MEA Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 317. MEA Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 318. MEA Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 319. MEA Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 320. Middle East Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 321. Middle East Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 322. Middle East Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 323. Middle East Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 324. Middle East Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 325. Africa Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 326. Africa Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 327. Africa Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 328. Africa Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 329. Africa Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 330. North America Biological Sample Handling, by Country USD Million (2021-2026)
  • Table 331. North America Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 332. North America Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 333. North America Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 334. North America Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 335. North America Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 336. United States Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 337. United States Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 338. United States Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 339. United States Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 340. United States Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 341. Canada Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 342. Canada Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 343. Canada Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 344. Canada Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 345. Canada Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 346. Mexico Biological Sample Handling, by Application USD Million (2021-2026)
  • Table 347. Mexico Biological Sample Handling, by Sample Type USD Million (2021-2026)
  • Table 348. Mexico Biological Sample Handling, by Risk Group Pathogens USD Million (2021-2026)
  • Table 349. Mexico Biological Sample Handling, by Extraction Technique USD Million (2021-2026)
  • Table 350. Mexico Biological Sample Handling, by Preservation Method USD Million (2021-2026)
  • Table 351. Research Programs/Design for This Report
  • Table 352. Key Data Information from Secondary Sources
  • Table 353. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biological Sample Handling: by Application USD Million (2015-2020)
  • Figure 5. Global Biological Sample Handling: by Sample Type USD Million (2015-2020)
  • Figure 6. Global Biological Sample Handling: by Risk Group Pathogens USD Million (2015-2020)
  • Figure 7. Global Biological Sample Handling: by Extraction Technique USD Million (2015-2020)
  • Figure 8. Global Biological Sample Handling: by Preservation Method USD Million (2015-2020)
  • Figure 9. South America Biological Sample Handling Share (%), by Country
  • Figure 10. Asia Pacific Biological Sample Handling Share (%), by Country
  • Figure 11. Europe Biological Sample Handling Share (%), by Country
  • Figure 12. MEA Biological Sample Handling Share (%), by Country
  • Figure 13. North America Biological Sample Handling Share (%), by Country
  • Figure 14. Global Biological Sample Handling share by Players 2020 (%)
  • Figure 15. Global Biological Sample Handling share by Players (Top 3) 2020(%)
  • Figure 16. Global Biological Sample Handling share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Alliance Pharma (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Alliance Pharma (United Kingdom) Revenue: by Geography 2020
  • Figure 20. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 22. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 23. Becton Dickinson (United States) Revenue: by Geography 2020
  • Figure 24. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 25. Sigma-Aldrich (United States) Revenue: by Geography 2020
  • Figure 26. BioRepository Resources, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 27. BioRepository Resources, LLC (United States) Revenue: by Geography 2020
  • Figure 28. Brooks Automation, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Brooks Automation, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Conversant Bio. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Conversant Bio. (United States) Revenue: by Geography 2020
  • Figure 32. Cryopoint (United States) Revenue, Net Income and Gross profit
  • Figure 33. Cryopoint (United States) Revenue: by Geography 2020
  • Figure 34. Fisher BioServices (United States) Revenue, Net Income and Gross profit
  • Figure 35. Fisher BioServices (United States) Revenue: by Geography 2020
  • Figure 36. Indivumed GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 37. Indivumed GmbH (Germany) Revenue: by Geography 2020
  • Figure 38. Masy BioServices (United States) Revenue, Net Income and Gross profit
  • Figure 39. Masy BioServices (United States) Revenue: by Geography 2020
  • Figure 40. Sentry BioPharma Services (United States) Revenue, Net Income and Gross profit
  • Figure 41. Sentry BioPharma Services (United States) Revenue: by Geography 2020
  • Figure 42. ProteoGenex (United States) Revenue, Net Income and Gross profit
  • Figure 43. ProteoGenex (United States) Revenue: by Geography 2020
  • Figure 44. ReproCELL Europe Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 45. ReproCELL Europe Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 46. Tescor Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. Tescor Inc. (United States) Revenue: by Geography 2020
  • Figure 48. Technidata (France) Revenue, Net Income and Gross profit
  • Figure 49. Technidata (France) Revenue: by Geography 2020
  • Figure 50. Global Biological Sample Handling: by Application USD Million (2021-2026)
  • Figure 51. Global Biological Sample Handling: by Sample Type USD Million (2021-2026)
  • Figure 52. Global Biological Sample Handling: by Risk Group Pathogens USD Million (2021-2026)
  • Figure 53. Global Biological Sample Handling: by Extraction Technique USD Million (2021-2026)
  • Figure 54. Global Biological Sample Handling: by Preservation Method USD Million (2021-2026)
  • Figure 55. South America Biological Sample Handling Share (%), by Country
  • Figure 56. Asia Pacific Biological Sample Handling Share (%), by Country
  • Figure 57. Europe Biological Sample Handling Share (%), by Country
  • Figure 58. MEA Biological Sample Handling Share (%), by Country
  • Figure 59. North America Biological Sample Handling Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alliance Pharma (United Kingdom)
  • Abbott Laboratories (United States)
  • Becton Dickinson (United States)
  • Sigma-Aldrich (United States)
  • BioRepository Resources, LLC (United States)
  • Brooks Automation, Inc. (United States)
  • Conversant Bio. (United States)
  • Cryopoint (United States)
  • Fisher BioServices (United States)
  • Indivumed GmbH (Germany)
  • Masy BioServices (United States)
  • Sentry BioPharma Services (United States)
  • ProteoGenex (United States)
  • ReproCELL Europe Ltd. (United Kingdom)
  • Tescor Inc. (United States)
  • Technidata (France)
Additional players considered in the study are as follows:
PrecisionMed (United States) , ProMedDx (United States) , SciSafe (United States)
Select User Access Type

Key Highlights of Report


Feb 2021 241 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biological Sample Handling Market Quantitative research analysis
Global Biological Sample Handling Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Biological Sample Handling market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Biological Sample Handling market are Alliance Pharma (United Kingdom), Abbott Laboratories (United States), Becton Dickinson (United States), Sigma-Aldrich (United States), BioRepository Resources, LLC (United States), Brooks Automation, Inc. (United States), Conversant Bio. (United States), Cryopoint (United States), Fisher BioServices (United States), Indivumed GmbH (Germany), Masy BioServices (United States), Sentry BioPharma Services (United States), ProteoGenex (United States), ReproCELL Europe Ltd. (United Kingdom), Tescor Inc. (United States) and Technidata (France), to name a few.
In this highly competitive & fast evolving Biological Sample Handling industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Biological Sample Handling Market Report?

Have a Query? Click Here

Other Related Reports

Biofilms Treatment Comprehensive Study by Type (Biofilm Disruptors, Antimicrobial Treatments, Antibiotic Medication, Photo Inactivation, Others), Application (Hospitals, ASCs, and Wound Care Centers,...
$ 3750
Bacteriological Agar Comprehensive Study by Type (Bacteriological Agar Type A, Bacteriological Agar Type E), Application (Food Industry, Pharmaceutic, Cosmetics, Daily Chemical, Scientific Research),...
$ 3650
Human Organoids Comprehensive Study by Type (Brain Organoids, Kidney Organoids, Lung Organoids, Intestine Organoids, Liver Organoids, Others), Application (Study of Infection Biology, Genetic Enginee...
$ 3750
Human Milk Glycans Comprehensive Study by Application (Hospitals, Clinics, Pharmacies), Components (Macro-micro Nutrients, Water, Human Milk), Forms (Liquid, Powder) Players and Region - Global Marke...
$ 3500
Paraneoplastic Pemphigus Comprehensive Study by Therapy (High Dose Corticosteroids, Steroid Sparing Agents, Others), Medication (Prednisone, Azathioprine, Ciclosporin, Cyclophosphamide, Others), Tumo...
$ 3650
Antibody Validation Comprehensive Study by Type (Standard Antibody Validation, Enhanced Antibody Validation), Antibodies (IgG, IgM, IgA, IgD, IgE), Assays (Western blot (WB), Immunohistochemistry (IH...
$ 3450